+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Clinical Microbiology Market by Product, Specimen Type, End-User, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5337233
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Clinical Microbiology Market grew from USD 7.80 billion in 2023 to USD 8.68 billion in 2024. It is expected to continue growing at a CAGR of 10.91%, reaching USD 16.12 billion by 2030.

The field of clinical microbiology focuses on the study and application of microorganisms causing diseases in humans and animals, enabling disease diagnosis, treatment, and prevention. This market’s necessity is underscored by the growing prevalence of infectious diseases, increasing antibiotic resistance, and technical advancements in molecular diagnostics. Its applications span across various healthcare facilitation areas, notably laboratory diagnostics and clinical research, emphasizing the importance of rapid and accurate pathogen detection. End-users primarily include hospitals, diagnostic laboratories, academic and research institutions, and biotechnology companies. Key growth influencers include burgeoning investments in healthcare infrastructure, increasing awareness of early disease detection, and government initiatives promoting R&D funding. Emerging opportunities lie in the development of rapid point-of-care tests and next-generation sequencing technologies, which can enhance the reliability and speed of diagnostics. Recommendations include capitalizing on partnerships with biotech firms for technological innovations and investing in expanding testing capabilities to address the rising demand for quick and accurate diagnostic solutions. However, the market faces limitations such as high costs of advanced diagnostic tools, stringent regulatory frameworks, and skill shortages in operating sophisticated diagnostic technologies. These challenges can result in slower market penetration, particularly in developing regions. Innovation can thrive on enhancing the specificity and sensitivity of diagnostic assays, integrating AI for better microbial analysis predictions, and automating laboratory processes to reduce human error. Research could explore developing cost-effective, scalable diagnostic solutions and personalized medicine applications. The clinical microbiology market is characterized by rapid technological evolution, a need for regulatory compliance, and competition among key players focusing on product differentiation. Maintaining competitive advantage requires constant innovation and strategic adaptability to emerging trends and market needs.

Understanding Market Dynamics in the Clinical Microbiology Market

The Clinical Microbiology Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing use of clinical microbiology in managing and controlling infectious diseases
    • Favorable government and private organizations support, and initiatives in cancer diagnosis and research
  • Market Restraints
    • Limited availability of skilled professionals, equipment and infrastructure
  • Market Opportunities
    • Technological advancement in clinical microbiology products and processes
    • Introduction of point-of-care microbiology testing
  • Market Challenges
    • Problems concerning quality assurance and management in clinical microbiology laboratories

Exploring Porter’s Five Forces for the Clinical Microbiology Market

Porter’s Five Forces framework further strengthens the insights of the Clinical Microbiology Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Clinical Microbiology Market

External macro-environmental factors deeply influence the performance of the Clinical Microbiology Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Clinical Microbiology Market

The Clinical Microbiology Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Clinical Microbiology Market

The Clinical Microbiology Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Microbiology Market, highlighting leading vendors and their innovative profiles. These include ELITech Group, Beckman Coulter, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Rapid Micro Biosystems, Inc., Kyokuto Pharmaceutical Industrial Co., Ltd., Hardy Diagnostics, SSI Diagnostica A/S, QIAGEN N.V., Merck KGaA, F. Hoffmann-La Roche Ltd., Liofilchem S.r.l., 3M Company, Bio-Rad Laboratories, Inc., bioMérieux S.A., Abbott Laboratories, COPAN Diagnostics Inc., Cardinal Health, Inc., Vircell S.L., TCS Biosciences Ltd., Clinichem Ltd., Advanced Instruments, LLC, B. Braun SE, Pro Lab Diagnostics Inc., Prestige Diagnostics U.K. Ltd., Laboratorios Conda, S.A., Becton, Dickinson and Company, Shimadzu Corporation, HORIBA, Ltd., and Diagnóstica Longwood S.L..

Market Segmentation & Coverage

This research report categorizes the Clinical Microbiology Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Instruments
    • Reagents
  • Specimen Type
    • Blood
    • Body fluids
    • Cerebrospinal Spinal Fluid
    • Fecal
    • Saliva
    • Serum
    • Synovial Fluid
    • Urine
  • End-User
    • Academic & Research Institutes
    • Hospitals & Care Providers
    • Laboratories
  • Application
    • Autoimmune Diseases
    • Cardiology
    • Diabetes
    • Drug Testing
    • Gastrointestinal Diseases
    • Nephrology
    • Oncology
    • Periodontal Diseases
    • Respiratory Diseases
    • Sexually Transmitted Diseases
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing use of clinical microbiology in managing and controlling infectious diseases
5.1.1.2. Favorable government and private organizations support, and initiatives in cancer diagnosis and research
5.1.2. Restraints
5.1.2.1. Limited availability of skilled professionals, equipment and infrastructure
5.1.3. Opportunities
5.1.3.1. Technological advancement in clinical microbiology products and processes
5.1.3.2. Introduction of point-of-care microbiology testing
5.1.4. Challenges
5.1.4.1. Problems concerning quality assurance and management in clinical microbiology laboratories
5.2. Market Segmentation Analysis
5.2.1. Product: Use of laboratory instruments in clinical microbiology assessments
5.2.2. Specimen Type: Preference for serum samples in serological testing to detect past or current infections
5.2.3. End-User: Adoption of clinical microbiology in laboratories and research institutes to provide detailed insights about infectious disease conditions
5.2.4. Application: Increasing use of clinical microbiology to diagnose gastrointestinal (GI) diseases by identifying causative pathogens
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Clinical Microbiology Market, by Product
6.1. Introduction
6.2. Instruments
6.3. Reagents
7. Clinical Microbiology Market, by Specimen Type
7.1. Introduction
7.2. Blood
7.3. Body fluids
7.4. Cerebrospinal Spinal Fluid
7.5. Fecal
7.6. Saliva
7.7. Serum
7.8. Synovial Fluid
7.9. Urine
8. Clinical Microbiology Market, by End-User
8.1. Introduction
8.2. Academic & Research Institutes
8.3. Hospitals & Care Providers
8.4. Laboratories
9. Clinical Microbiology Market, by Application
9.1. Introduction
9.2. Autoimmune Diseases
9.3. Cardiology
9.4. Diabetes
9.5. Drug Testing
9.6. Gastrointestinal Diseases
9.7. Nephrology
9.8. Oncology
9.9. Periodontal Diseases
9.10. Respiratory Diseases
9.11. Sexually Transmitted Diseases
10. Americas Clinical Microbiology Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Clinical Microbiology Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Clinical Microbiology Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Wichita State’s MDL Lab Shifting To Microbiology.
13.3.2. Cambridge Start-Up Won Funding To Develop New Diagnostics.
13.3.3. Transformative Agreement Signed Between The Microbiology Society And Indian Institute Of Science Bangalore
13.3.4. Hardy Diagnostics Awarded Manual Microbiology Agreement With Premier, Inc.
13.3.5. Department of Medical Microbiology Unveils Four New Projects Worth USD 6.8 Million and New Website.
13.3.6. ASM Funded for Inclusive Microbiology Leaders Program.
13.3.7. MAESTRIA, A New Generation Microbiology Middleware Developed by Biomérieux to Optimize Laboratory Workflow and Improve Patient Care.
13.3.8. Beckman Coulter and MeMed to Expand Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Viral and Bacterial Infections.
13.3.9. BD Introduces Fully Automated Robotic Track System for Microbiology Labs.
13.3.10. FASTinov Collaborates with Beckman Coulter Life Sciences to Bring Ultra-Rapid 2h-AST Disruptive Technology to Clinical Microbiology Laboratories.
13.3.11. Upstate Planned To Launch A Multidisciplinary Lyme And Tick-Borne Disease Treatment Center.
13.3.12. Bio-Rad Expands QC Range for Abbott Diagnostic Platforms.
13.3.13. Federal Funds Set To Boost U of A’s Ability To Handle Highly Infectious Pathogens.
13.3.14. Oxford Gets £122m (USD 136.63 Million) Funding for Healthcare Research.
13.3.15. Sci-Tech Daresbury’s Perfectus Biomed Group Acquired by Global Medical Device Testing Leader NAMSA.
13.3.16. HORIBA Veterinary Adds New Rapid PCR Test for Difficult to Diagnose Parasite.
13.3.17. ValitaCell Joins Beckman Coulter Life Sciences.
13.3.18. Global Access Diagnostics Acquires Manufacturing Rights for IT-LEISH Rapid Diagnostic Test From Bio-Rad Laboratories.
13.3.19. SSI Diagnostica Continues a Strong Growth Journey.
13.3.20. BD, Accelerate Diagnostics Announce Global Commercial Collaboration.
13.3.21. SGS Launched New Microbiology Laboratory In Phoenix, Arizona.
13.3.22. Israel: EUR 22 Million (Usd 24.26 Million) EU Backing for Israeli Microbiology Diagnostic Player Pocared.
13.3.23. DCN Dx Acquires Microbiological Testing Products Company Biomed Diagnostics.
13.3.24. bioMérieux Strengthens its Commitment to Fight Antimicrobial Resistance with the Acquisition of Specific Diagnostics, An Innovative Company Focusing on Fast AST Solutions.
13.3.25. NIH Funded New Tuberculosis Research Advancement Centers.
13.3.26. Raue Advises Sonic Healthcare on the Acquisition of Diagnosticum Laboratory Group.
13.3.27. ATCC Announces Expansion of its Bioinformatics Data Platform with QIAGEN.
13.3.28. Hardy Diagnostics Now Offers the BioCode MDx-3000.
13.3.29. Merck Announced Organizational Transformation of Life Science Business Sector To Strengthen Cdmo Offering And Accelerate Future Growth.
13.3.30. COPAN Diagnostics Announces Another Giant Step in the Evolution of Artificial Intelligence in Clinical Microbiology.
List of Figures
FIGURE 1. CLINICAL MICROBIOLOGY MARKET RESEARCH PROCESS
FIGURE 2. CLINICAL MICROBIOLOGY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. CLINICAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. CLINICAL MICROBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CLINICAL MICROBIOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CLINICAL MICROBIOLOGY MARKET DYNAMICS
TABLE 7. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BODY FLUIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CEREBROSPINAL SPINAL FLUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY FECAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SYNOVIAL FLUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DRUG TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PERIODONTAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 49. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 53. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 71. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 75. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 83. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 91. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 95. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 99. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 103. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 107. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 111. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 118. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 120. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 124. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 128. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 132. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 136. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 140. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 144. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 148. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 152. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 156. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 160. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 164. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 176. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. SPAIN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. SPAIN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 180. SPAIN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. SPAIN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 184. SWEDEN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. SWEDEN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. SWITZERLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. SWITZERLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 188. SWITZERLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. SWITZERLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. TURKEY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. TURKEY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 192. TURKEY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 193. TURKEY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. CLINICAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 203. CLINICAL MICROBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Clinical Microbiology market, which are profiled in this report, include:
  • ELITech Group
  • Beckman Coulter, Inc.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Rapid Micro Biosystems, Inc.
  • Kyokuto Pharmaceutical Industrial Co., Ltd.
  • Hardy Diagnostics
  • SSI Diagnostica A/S
  • QIAGEN N.V.
  • Merck KGaA
  • F. Hoffmann-La Roche Ltd.
  • Liofilchem S.r.l.
  • 3M Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux S.A.
  • Abbott Laboratories
  • COPAN Diagnostics Inc.
  • Cardinal Health, Inc.
  • Vircell S.L.
  • TCS Biosciences Ltd.
  • Clinichem Ltd.
  • Advanced Instruments, LLC
  • B. Braun SE
  • Pro Lab Diagnostics Inc.
  • Prestige Diagnostics U.K. Ltd.
  • Laboratorios Conda, S.A.
  • Becton, Dickinson and Company
  • Shimadzu Corporation
  • HORIBA, Ltd.
  • Diagnóstica Longwood S.L.

Methodology

Loading
LOADING...

Table Information